Home
Investment
News & Views
Company News
news storage
Tristel ups divi as profits climb
Wed, 08 Feb, 2012
INVESTMENT NEWS
Company Search
Search QCK.COM
Investment Home
News & Views
Top Stories
Charting
Company Search
Watchlist
Market Reports
Market Buzz
Company News
Economic News
New Issues
Other News
Tristel ups divi as profits climb
Mon, 12 Oct 2009, 08:08:00
The continuing struggle to keep infections such as Chlorostrium Difficile out of hospitals helped disinfectant supplier <b>Tristel</b> post a rise in turnover and profits in the year to June 30. Tristel, whose products are based on chlorine dioxide chemistry, said revenues climbed to £6.8m from £6m over the same period the previous year, while pre-tax profits rose to £1.3m from £1.2m. It will lift the final dividend to 1.295p from 1.165p, taking the full-year dividend to 1.7p, compared with 1.55p over the previous year. Tristel also announced that it had licensed its chlorine dioxide chemistry to the Clorox Company, a US manufacturer and marketer of consumer and professional products. The partnership with the S&P 500-listed company is Tristel's second attempt to enter the US market. It abandoned earlier efforts due to regulatory hurdles. Tristel said it expects to remain well insulated from the public spending cuts that are expected to be implemented in the UK and Europe. 'There are well publicised performance targets for the control of hospital acquired infections and we cannot imagine a scenario in which they will be abandoned,' the firm said.
©2004-2009 QCK.com
